BR112018001313A2 - composição de zolpidem e processo para preparar a mesma - Google Patents

composição de zolpidem e processo para preparar a mesma

Info

Publication number
BR112018001313A2
BR112018001313A2 BR112018001313A BR112018001313A BR112018001313A2 BR 112018001313 A2 BR112018001313 A2 BR 112018001313A2 BR 112018001313 A BR112018001313 A BR 112018001313A BR 112018001313 A BR112018001313 A BR 112018001313A BR 112018001313 A2 BR112018001313 A2 BR 112018001313A2
Authority
BR
Brazil
Prior art keywords
preparing
zolpidem composition
zolpidem
composition
Prior art date
Application number
BR112018001313A
Other languages
English (en)
Other versions
BR112018001313B1 (pt
Inventor
Y Chaudhari Amol
S Wadhwani Jagdish
B Chaudhari Mahendra
S Kate Sujata
Original Assignee
Athena Drug Delivery Solutions Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athena Drug Delivery Solutions Pvt Ltd filed Critical Athena Drug Delivery Solutions Pvt Ltd
Publication of BR112018001313A2 publication Critical patent/BR112018001313A2/pt
Publication of BR112018001313B1 publication Critical patent/BR112018001313B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112018001313-7A 2015-07-23 2016-06-30 Composição de zolpidem e processo para preparar a mesma BR112018001313B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2793/MUM/2015 2015-07-23
IN2793MU2015 2015-07-23
PCT/IN2016/050211 WO2017013678A1 (en) 2015-07-23 2016-06-30 Zolpidem composition and process for preparing the same

Publications (2)

Publication Number Publication Date
BR112018001313A2 true BR112018001313A2 (pt) 2018-09-11
BR112018001313B1 BR112018001313B1 (pt) 2023-05-02

Family

ID=57834133

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001313-7A BR112018001313B1 (pt) 2015-07-23 2016-06-30 Composição de zolpidem e processo para preparar a mesma

Country Status (7)

Country Link
EP (1) EP3324971A1 (pt)
CN (1) CN107921045B (pt)
BR (1) BR112018001313B1 (pt)
CA (1) CA2993597A1 (pt)
MX (1) MX2018000939A (pt)
RU (1) RU2690159C1 (pt)
WO (1) WO2017013678A1 (pt)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005065640A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
ZA200606411B (en) * 2004-02-17 2008-05-28 Transoral Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
KR20150038745A (ko) * 2004-02-17 2015-04-08 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
US20070259040A1 (en) * 2006-05-01 2007-11-08 Cherukuri S R Novel triptan formulations and methods for making them
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20130078304A1 (en) * 2011-09-28 2013-03-28 Taiwan Biotech Co., Ltd. Controlled release formulation for treating sleep disorders
US20130143912A1 (en) * 2011-12-06 2013-06-06 Dr. Reddy's Laboratories Inc. Sublingual zolpidem formulations
CN102860997A (zh) * 2012-09-28 2013-01-09 天津市聚星康华医药科技有限公司 一种遮味的昂丹司琼口腔速溶膜及其制备方法

Also Published As

Publication number Publication date
EP3324971A4 (en) 2018-05-30
CN107921045B (zh) 2021-03-09
CN107921045A (zh) 2018-04-17
EP3324971A1 (en) 2018-05-30
CA2993597A1 (en) 2017-01-26
BR112018001313B1 (pt) 2023-05-02
MX2018000939A (es) 2018-06-07
WO2017013678A1 (en) 2017-01-26
RU2690159C1 (ru) 2019-05-31

Similar Documents

Publication Publication Date Title
DK3359095T3 (da) Automatiseret hånd
BR112016022458A2 (pt) formulação de poliuretano, método para rodução de um material de poliuretano, e, material de poliuretano
DK3242884T3 (da) Kationiske neurotoksiner
DK3341479T3 (da) LNA-G-Proces
DK3170627T3 (da) Redskab
BR112016025076A2 (pt) processo para a preparação de ciclosserinas substituídas
BR112016030604A2 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
CL2015002384S1 (es) Maquina para preparar bebidas
BR112017007069A2 (pt) composição sinérgica para osteoartrite
BR112016027819A2 (pt) Processo de preparação de derivados de tiazole
BR112016019843A2 (pt) processo de biorrefinamento
MA44385A (fr) Pince
DK3285558T3 (da) Græslægningsmaskine
FI20156045A (fi) Kationinen pintaliima-aine
GB201518570D0 (en) Blade positioning
BR112017008394A2 (pt) aparelho e método para dobrar
FI20155486A (fi) Karsintaterä
DE102014224930A8 (de) Fugeneinkehrmaschine
BR112018001313A2 (pt) composição de zolpidem e processo para preparar a mesma
ITUB20153989A1 (it) Marcatrice
ES1135628Y (es) Monoboya para vertido controlado
ES1189683Y (es) Maquina para fabricar pales
ES1183259Y (es) Maquina para despelonado de nueces
ES1166158Y (es) Tapa-colador para ollas exprés
BR112017007508A2 (pt) processo para preparação de trifluoroacetofenonas substituídas por halo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: ATHENA PHARMACEUTIQUES SAS (FR)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/06/2016, OBSERVADAS AS CONDICOES LEGAIS